Table 1.
IBS-C respondent demographics
| Total respondents N = 1311 |
|
|---|---|
| Female | 73% |
| Age, years, mean (SD) | 46.0 (15.6) |
| Age at symptom onset, years, mean (SD) | 43.6 (16.0) |
| Diagnosed by an HCP | 71% |
| Race/ethnicity | |
| White/non-hispanic | 65% |
| Black/non-hispanic | 10% |
| Mixed/non-hispanic | 5% |
| Other/non-hispanic | 4% |
| Hispanic | 17% |
| Highest education level | |
| High school—no graduation | 5% |
| High school—diploma/GED | 31% |
| College—no graduation | 23% |
| College—graduation | 30% |
| College—post-graduate | 12% |
| Current treatment to manage IBS-C symptoms | |
| Lifestyle changes | |
| General diet changes/home remedies | 28% |
| Increased activity and exercise | 21% |
| Meditation/yoga/relaxation techniques | 8% |
| Gluten-free diet | 7% |
| OTC treatment remedies | |
| Fiber | 27% |
| Stool softeners | 13% |
| Probiotics/prebiotics | 22% |
| Non-prescription laxatives | 8% |
| Non-prescription stimulant laxatives | 6% |
| Other | 3% |
| Prescription therapy | 12% |
CIC chronic idiopathic constipation, GED General Educational Development, HCP healthcare provider, IBS-C irritable bowel syndrome with constipation, OTC over the counter, SD standard deviation